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Abstract
Background: Mental illness remains undertreated in older adults, especially those that are
homebound. In response to access to care gaps, an innovative advanced practice registered nurse
(APRN) led Home-Based Psychiatric Care (HBPC) Program was developed as an adjunct to an
established home-based counseling agency. The program involves the research supported
provision of home-based psychiatric evaluations and medication management by the agency’s
PMHNP. Purpose/Objectives: To evaluate the HBPC Program’s effectiveness at increasing
access to timely and effective psychopharmacological treatment and management as evidenced
by: (a) an increased percentage of referred patients who are being managed by the agency’s
PMHNP, (b) a decrease in wait times for psychiatric evaluation, and (c) improvement in Global
Clinical Impression-Improvement scale (CGI-I) and Efficacy Index (CGI-E) scores. Intervention:
A retrospective program evaluation of the first 3 months (February to April 2019) of the HBPC
Program was conducted via the analysis of remotely mined data, collected from the agency's
internally shared quality improvement database. Results: At the 12-week mark, 60% of referred
patients were being managed by the agency's PMHNP, 13% had been assessed within 10 days,
and 33.3% had achieved a CGI-I score of ≤ 3 and an Efficacy Index score of ≥ 1.5. Implications:
The initial results are inconclusive, yet promising. If improved outcomes are realized over time,
the HBPC program is anticipated to improve this agency's ability to provide psychiatric care to
vulnerable homebound geriatric patients, by serving as an essential bridge that connects the
elderly with effective psychopharmacologic interventions.
Keywords: home-based psychiatric services, psychiatric house call, geropsychiatry
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More than two million United States citizens age 65 and older are in need of mental
healthcare, however, less than 50% of these individuals will be able to obtain adequate
psychiatric services (Ornstein et al., 2015). Homebound elders are particularly vulnerable, being
twice as likely to have one or more psychiatric disorders compared to their non-homebound
peers (Qiu et al., 2010). These patients are predominantly frail older adults, who often face
several practical barriers to seeking traditional outpatient services, such as limited mobility or
access to transportation (Ornstein et al., 2015; Qiu et al., 2010). Unfortunately, psychiatric
disorders are often overlooked and inadequately treated in the homebound elderly even though
research has shown they are at an increased risk of having depression, anxiety, and cognitive
impairment compared to the general population (Qiu et al., 2010). Left untreated or improperly
treated, these problems can have serious consequences, including suicide (Bruce & McNamara,
1992; Ornstein et al., 2015; Van Citters & Bartels, 2004). Consequently, policymakers and
researchers have been searching for more efficient and innovative approaches aimed at meeting
the psychiatric care needs of this underserved, vulnerable population.
Statement of Problem
Per the American Psychological Association (APA, 2015) position statement on ensuring
access and appropriate utilization of psychiatric services for the elderly, all older Americans
should have access to timely psychiatric consultation and effective treatment that includes
appropriate person-centered nonpharmacological and pharmacological interventions.
Unfortunately, mental illness remains undertreated in older adults, especially those that are
homebound, and few older adults with a recognized mental disorder are able to obtain access to
evidence-based psychiatric treatment (Van Citters & Bartels, 2004). While some of these cases
do reflect older adults, who declined to receive mental health services of their own accord, far
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too many of them reflect cases of older adults who were unable to access mental health treatment
due to barriers (e.g., limited mobility, lack of transportation, long wait times, limited income or
insurance coverage) posed by the healthcare system. Therefore, there is a clear need for new
innovative, evidence-based psychiatric care delivery models designed to reach out to the aged
population that provide timely and effective person-centered nonpharmacological and
pharmacological interventions.
Background and Significance
Although estimates vary, it is anticipated that the number of older adults with mental and
behavioral health problems will almost quadruple, from 4 million in 1970 to 15 million in 2030
(APA, 2018). Currently, over 20% of U.S. adults aged 60 and over suffer from a mental or
neurological disorder of some type and 6.6% of all disability among people over 60 years is
attributed to mental and neurological disorders (World Health Organization [WHO], 2017). The
most common mental and neurological disorders in this age group are dementia and depression
(WHO, 2017). However, anxiety disorders affect 3.8% of the older population, and around a
quarter of suicides are among people aged 60 or above (WHO, 2017).
While everyone faces multiple risk factors for the development of mental health problems
throughout their life, certain developmental periods are more stressful than others. Older adults,
for example, may experience life stressors common to all people, but also stressors that are more
common in later life, like a significant ongoing loss in capacities and a decline in functional
ability (Qiu et al., 2010). For instance, it is common for older adults to experience progressively
reduced mobility, chronic pain or other health problems as they age (Reckrey et al., 2015). In
addition, older people are more likely to experience events such as bereavement, or a drop in
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socioeconomic status with retirement, placing them at increased risk for the development of
mental health problems (Reckrey et al., 2015).
Elders with behavioral health conditions face a multitude of physical and economic
barriers that prevent them from accessing and receiving necessary psychiatric treatment.
Common barriers elders face in accessing psychiatric treatment, include limited mobility or
homebound status; long wait times for services, limited income or insurance coverage; lack of
transportation; stigma around mental health treatment; lack of coordination among providers;
and inadequate services and social support (Qiu et al., 2010). Older adults also tend to have other
comorbid medical conditions (e.g., hypertension, congestive heart failure, diabetes mellitus,
cancer), which can further complicate their ability to find a psychiatric provider capable of
managing their complex health issues (Qiu et al., 2010).
Unidentified and improperly treated psychiatric illnesses, like depression, are associated
with an increased risk of suicidal ideation in older adults (Qiu et al, 2010; Reckrey et al., 2015).
Mental illness in older adults has also been associated with adverse health effects including
higher rates of cognitive impairment or anxiety, medication nonadherence, and increased side
effects (Reifler & Bruce, 2014). For this reason, prompt recognition and treatment of mental,
neurological, and substance use disorders in older adults is essential. Both psychosocial
interventions and medicines are recommended (APA, 2015). Unfortunately, traditional clinicbased treatment options haven't been very receptive to the unique needs of the elderly, especially
those who are homebound and face unique challenges to accessing care.
To meet this vulnerable population's needs, newer innovative models of evidence-based
psychiatric care delivery are needed. One promising treatment modality of care delivery that is
proving to be ideal for elderly psychiatric patients unable or unwilling to access care through
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community mental health clinics is the psychiatric house call. While descriptions of in-home
geriatric mental health services date back at least a quarter of a century, there has been a recent
resurgence in popularity of this model of psychiatric care in both the research and clinical
setting. This care delivery model is supported by a growing body of evidence supporting its
ability to increase access to appropriate and effective psychiatric care (i.e., person-centered
nonpharmacological and pharmacological interventions) and improve psychiatric outcomes for
homebound elderly patients with mental health illnesses (APA, 2015; Bruce, Van Citters &
Bartels, 2005; Van Citters & Bartels, 2004).
Organizational Assessment
The local mental health agency where this program evaluation was conducted, consists of
a group of independent contractors that includes 14 licensed clinical social workers (LCSW), two
psychologists, one psychiatric mental health nurse practitioner (PMHNP) and one psychiatrist;
all of whom provide psychiatric services in the private homes (e.g. personal residence,
independent living, or assisted living) of vulnerable homebound geriatric psychiatric patients
who live in San Antonio, Texas. The group was established and is currently owned by two
LCSWs, who in addition to providing therapy services themselves also provide practice
management, to include marketing, referrals, billing, and support, for the other independent
contractors. Medicare, Medicaid, and Tricare insurance plans are accepted, as well as many other
secondary commercial insurances. There were over 500 current patients being seen for in-home
counseling by this agency at the time of initial assessment and while this agency predominantly
serves geriatric patients 65 years of age and older with mental health issues; ages of patients
ranged from 42 years to 93 years.
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Psychiatric services offered at the time of initial assessment included in-home counseling
and behavioral interventions provided by contracted LCSWs and psychologists, however none of
these mental health professionals were able to prescribe medications. Thus, any patient needing
psychopharmacological treatment and management had to be referred out. The percentage of
active patients referred for medication management at the time of initial assessment, that had
successfully obtained psychopharmacological services was only 35.6%. The top five reasons
reported for this low percentage of referred clients receiving care included, lack of
transportation, difficulty leaving home without assistance, lack of providers who accepted
Medicare, long wait times, and the expense of co-pays.
To address this access to psychopharmacological treatment and management care gap
and meet APA guidelines, the agency developed an innovative advance practice registered nurse
(APRN) led Home-Based Psychiatric Care (HBPC) Program as an adjunct to their already
established home-based counseling agency. The new HBPC program involves the research
supported provision of home-based psychiatric evaluations and medication management by the
agency’s PMHNP.
HBPC Program
Detailed below is a brief overview of the APRN-led HBPC program. All patients in need
of psychiatric care were referred either directly to agency staff member, by phone, or by
emailing/faxing one of the agency's completed standardized referral forms. All referred patients
were then directly contacted by one of the agency owners to briefly explain services offered (e.g.
the standard in-home counseling services provided by LCSWs and/psychologists and the newly
available HBPC program, which provides medication management by the agency’s PMHNP)
and set up an initial intake appointment to determine eligibility, answer questions, review the
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agency's policies and sign required consent forms. Patients selected for the HBPC Program were
then contacted directly by the agency’s PMHNP to set up an initial evaluation. Once evaluated,
the PMHNP developed an acceptable treatment plan with the patient, based on the assessment
results and the patient's goals, ordered baseline laboratory blood tests, and set up an
individualized follow-up schedule. Paper-based prescriptions and lab orders were provided
directly to the patient or designated caregiver as necessary.
Stakeholders
Stakeholders are individuals that have a vested interest in clinical decisions and outcomes
of an organization. The primary stakeholders of this local mental health agency were the patients,
patients’ families, providers, and insurance companies. The patient's interests in the new HBPC
program stemmed from the lack of current access to care due to: (a) a shortage of psychiatric
providers who accept Medicaid; (b) long appointment wait times; and (c) a combination of
practical barriers (e.g., immobility, lack of transportation, etc.), which prevented access to
traditional outpatient psychiatric care programs. Conversely, provider’s interest was based on the
desire to provide evidence-based care, advance patient outcomes, and expand access to care for
this vulnerable population. Insurance agencies and other third-party payer’s interest lied on the
desire to minimize direct and indirect cost due to the provision of unnecessary treatment
(Schreck, 2018). All stakeholders involved had a stake in the success of the outcomes and were
supportive of the proposed change.
Organizational Readiness for Change
Informal interviews of leadership and staff and observations related to key readiness to
change indicators were utilized to determine the preparation of this agency to implement this
change in practice (R. Gainer, D. Welmaker, & I. Gilliland, personal communication, October

PROGRAM EVALUATION OF APRN-LED HBPC PROGRAM

13

15, 2018). Key indicators of change readiness evaluated included; (a) the investment of
leadership, (b) organizational alignment with goals, (c) culture and infrastructure level of
support, and (d) past organizational experiences with change. The assessment found that (a) the
agency’s leadership recognized the need for change, (b) agreed about what changes were
required, (c) prepared to support the change, and (d) were committed to this transformation.
Project Identification
As discussed above, to address access to psychopharmacological treatment and
management care gaps, this agency developed an innovated APRN-led HBPC Program, which
provided research supported in-home psychiatric evaluations and medication management by the
agency’s PMHNP, as an adjunct to the agency’s already established home-based counseling
service. To determine the effect of this change in practice, a retrospective program evaluation of
the first 3 months of the agency’s HBPC Program was conducted. To monitor the change, wait
times from referral to initial evaluation and the percentage of referred patients who came under
the care of the agency’s PMHNP in the first 3 months were tracked. Additionally, the Clinical
Global Impression Improvement (CGI-I) scale (which compares the patient's baseline condition
to his/her current condition on a seven-point scale from very much improved to much worse) and
the Clinical Global Impression Efficacy Index (CGI-E) scale (which compares the patient's
baseline condition to a ratio of current therapeutic benefit and severity of side effects on a fourpoint scale from none to outweighs therapeutic effect) were utilized. The CGI Scale global
measurements are well-established standard measures, that are commonly used in FDA
psychopharmacological trials as outcome measures that can be utilized together or independently
(Guy, 1976).
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Purpose
The purpose of this program evaluation project is to evaluate the HBPC Program’s
effectiveness at increasing access to timely and effective psychopharmacological treatment and
management for vulnerable geriatric patients ages 60 years of age and older living in San
Antonio, Texas.
Objectives
The first objective of this project was to increase the percentage of patients in need of
medication management that were able to successfully obtain psychopharmacological treatment
and management services by the agency’s PMHNP.
The second objective of this project was to decrease patient wait times for an initial
psychiatric evaluation after being referred for medication management.
The third objective of this project was to increase the percentage of patients who
clinically improved after receiving appropriate psychopharmacological treatment, indicated by
achieving a CGI-I score of 3 or lower after 8 weeks of treatment (appendix A).
The fourth objective is to increase the percentage of patients who received effective
psychopharmacological treatment, indicated by achieving a Clinical Global Impression Efficacy
Index (CGI-E) 1.5 or less after 8 weeks of treatment (appendix A).
Anticipated Outcomes
1. By the end of April 2019, 75% or more of HBPC patients, referred for medication
management would be under the care of the agency’s PMHNP.
2. By the end of April 2019, 75% or more of HBPC patients, referred for medication
management, would be evaluated by the agency’s PMHNP within 10 days.
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3. By the end of April 2019, 40% or more of HBPC patients would achieve a CGI-I score of
3 or lower after at least 8 weeks of treatment.
4. By the end of April 2019, 75% or more of HBPC patients would achieve a CGI-E score
of 1.5 or greater after at least 8 weeks of treatment.
Summary and Strength of Evidence
The evidence for this project consists of seven articles from peer-reviewed journals,
evaluated using Melnyk and Fineout-Overholt (2011) model. Included in these seven articles are
two systematic reviews (Level I), one cohort study (Level IV), one cross-sectional study (Level
IV), and three descriptive studies (Level V & VI) described below.
Supporting Evidence
A cross-sectional study (Level IV evidence), that examined the use of behavioral health
services, treatment preferences, facilitators and barriers to service use among older adults
receiving home-based services, demonstrated that while this population was interested in
obtaining a variety of behavioral health services, they rarely seek them out due to perceived
barriers to care (Gum, Iser & Petkus, 2010). The most common barriers to service noted in this
study were affordability (71.8%), difficulty traveling (62.7%), and lack of transportation (45.8%)
(Gum et al., 2010). These findings reflect a common trend in the literature that indicates a strong
need for innovative home-based psychiatric care delivery models which can meet the unique
needs of the homebound elderly. The provision of home-based mental health services for older
adults, therefore, has the potential to enhance access and utilization of psychiatric services in this
vulnerable population. While models vary in structure, they typically include some combination
of the following elements: (a) individual case management; (b) consultation to primary care
physicians who provide in home care; (c) in-home counseling services; (d) in-home psychiatric
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medication treatment and management by a psychiatrist or psychiatric APRN, and (e) provision
of and efforts to maximize community-based mental health resources (Reifler & Bruce, 2014).
Several studies support incorporating nonpharmacological and pharmacological
psychiatric intervention services into home-based care models to adequately address the mental
health needs of the homebound geriatric population (Johnston et al., 2010; Karlin, Karel &
Meeks, 2013; Reifler & Bruce, 2014). One large cohort study (Level IV evidence), for example,
found that home-based psychiatric care delivery not only improved the identification of
psychiatric conditions in the homebound community but also facilitated their optimal treatment,
thereby improving patient symptoms and quality of life while reducing the burden on
homebound patients and their caregivers (Reckrey et al., 2015). These studies further reflect the
findings of two systematic reviews (Level I Evidence), which both provide substantial support
for the utilization of home-based mental health services to improve psychiatric symptoms in
older adults who often have limited access to traditional practice-based models of care (Bruce et
al., 2005; Van Citters & Bartels, 2004).
Findings
Overall, the evidence supports the utilization of home-based psychiatric treatment models
that provide both nonpharmacological and pharmacological interventions to (a) improve access
to effective evidence-based psychiatric care and (b) improve psychiatric outcomes for the
vulnerable elderly population. The overall strength of the articles was acceptable to use as
evidence to support this project.
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Methods
To determine the effectiveness of the HBPC program at increasing access to timely and
effective psychopharmacological treatment and management, a retrospective program evaluation
of the first 3 months (i.e., February to April 2019) was conducted.
Setting and Population
Participants consisted of geriatric patients in need of psychopharmacological treatment
and management who lived in the San Antonio, Texas area. Patients were included in the
evaluation if they had been referred to the HBPC program within the inclusion period (February
1, 2019, through April 30, 2019), were greater than 60 years old, spoke and read English, and
were recorded in the agency’s password protected deidentified quality improvement database.
However, only participants that received at least 8 weeks of treatment prior to the end of the
inclusion period that had post outcome measures documented in the agency’s quality
improvement database were included in the final analysis used to determine the program's effect
on patient outcomes. Any patients who did not fulfill the above criteria were excluded.
Procedure
This retrospective program evaluation was accomplished via analysis of key demographic
and outcome measures collected as part of the agency’s standard of care, remotely mined from a
specially created password protected deidentified quality improvement database and did not
require any patient interaction.
Data collection. The following demographic data were extracted from the agency’s
deidentified quality improvement database: (a) gender (male, female), (b) age (in years), (c)
relationship status (single, married, divorced, widow/widower), (d) number of psychiatric
disorders (0-1, 2, 3, 4+), (e) past psychiatric medication use (Yes, No), (f) number of psychiatric
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medication taken at baseline (0, 1, 2, 3, 4, 5+) and (g) number of total medications taken at
baseline (<1, 1-5, 6-10, 11+). Additionally, the following outcome measures were collected from
the quality improvement database: (a) reason for referral (i.e. psychiatric diagnosis), (b) referral
date, (c) psychiatric evaluation appointment date, (d) treatment status (i.e. never seen, active,
transfer, discharged), (e) Post intervention CGI-I & CGI-E scale scores.
Measurements. To monitor this change in practice, wait times from referral to initial
psychiatric evaluation and the percentage patients referred for medication management who
came under the care of the under the agency’s PMHNP were tracked. Additionally, the CGI-I
and CGI-E scale scores after 8 weeks of treatment were measured (see appendix A). As stated
above, CGI-I and CGI-E global measurements are easily recognizable and universally known
efficacy measures, commonly utilized in FDA psychopharmacological trials. These scales take
less than 5 minutes for a clinician to complete and are applicable across all psychiatric disease
states and all medications, no matter the population.
Data analysis. Abstracted data were entered into a password protect Excel database and
transferred to SPSS statistical software. A range of descriptive statistics were used to summarize
outcome results and the sample population. Baseline descriptors were summarized as mean and
standard deviations for continuous variables and as frequencies and percentages for categorical
variables.
Evaluation Plan
To evaluate the effect of the HBPC Program on to timely access to psychiatric care the
following extracted outcome data were analyzed: (a) Percentage of referred patients under the
care of the agency’s PMHNP (i.e., percentage of clients referred for medication management
divided by those currently receiving care); (b) Wait times to be seen by the agency’s PMHNP
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(i.e., difference between the referral and evaluation dates) were analyzed and compared to preintervention wait time benchmarks. The program was to be considered successful at improving
timely access to psychiatric care, if, by the end of April 2019, 75% or more of HBPC patients
referred for medication management, were evaluated within ten days and/or were currently under
the care of the agency’s PMHNP.
To evaluate the effect of the HBPC Program on patients’ clinical outcomes, post
intervention CGI-I & CGI-E scale scores were analyzed and compared to pre-intervention
outcome benchmarks set for the program. The program would be considered successful at
providing effective psychopharmacological treatment and improving patient clinical outcomes if
by the end of April 2019 and at least 8 weeks of treatment (a) 40% or more of HBPC patients
achieve a CGI-I score of 3 or lower, and/or (b) 75% or more achieve a CGI-E score of 1.5 or
greater after.
Organizational Barriers and Facilitators
The agency’s leadership commitment to allocate time and resources to implementing
their new APRN-lead HBPC program and clinical staff agreement on the importance of
addressing the identified care gaps, all helped to ensure that everyone was on the same page and
motivated to see the project implemented. Furthermore, the agency’s standard practice of
collecting and mining of key deidentified demographic and clinical data for quality improvement
purposes helped to streamline the evaluation process. However, there were still design barriers
that hindered the evaluation process including the agency’s use of paper-based prescriptions and
lab orders due to the lack of electronic prescribing and lab ordering EMR functions and ongoing
uncertainty in correct billing codes that threatened proper reimbursement.
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Ethical Considerations
Prior to beginning the project, agency approval was received (November 12, 2018) to
conduct the planned retrograde program evaluation of the HBPC Program and the University of
the Incarnate Word Institutional Review Board reviewed this project to ensure compliance with
federal, state, local, and university regulations. Participation in the HBPC program was
completely voluntary and did not pose any additional risks to patients than standard outpatientbased psychiatric treatment. Eligible participants who chose to enroll were not be provided any
compensation for their participation in this project. The participants’ privacy and confidentiality
were maintained and protected throughout the project. All data collection for this retrospective
program evaluation was remotely mined from a specially created password protected
deidentified quality improvement database and did not require any patient interaction. Lastly, all
findings were reported only as aggregate data to further their anonymity.
Results
Nine women (60%) and six men (40%), with a majority of the participants being single
(53%) or widow/widowers (33%) were enrolled during the eligibility window of this project.
Ages ranged from 60 years to 92 years old, with a mean age of 73.9 (SD =11.2) years. Most
participants had only one pre-existing psychiatric diagnosis at baseline, with major depression
(recurrent) (40%), generalized anxiety disorder (27%), and adjustment disorder with mixed
anxiety and depressed mood (20%) being the most common. Most participants also had a prior
history of psychiatric medication use (80%) and were currently taking psychiatric medication at
the time of enrollment (73%). However, due to credentialing delays, only three of these
participants actually received the full 8 weeks of treatment required to be included in the clinical
outcomes final analysis. A majority of the participants included in the clinical outcome final
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analysis were female (67%), were single (100%), had three (33%) to four (67%) pre-existing
psychiatric diagnosis, and all had a prior and current history of being treated with psychiatric
medications. Ages ranged from 60 years to 79 years, with a mean age of 75.1 (SD = 9.6) years.
Findings
Wait times for an initial psychiatric evaluation among participants who were seen ranged
from 3 days to 45 days, with a mean wait time of 20.8 (SD = 13.1) days. Table 2 shows initial
psychiatric evaluation wait times for study participants and their corresponding descriptive
statistics. The CGI-I scores of the three participants included in the clinical outcomes final
analysis (i.e., those that received at least 8 weeks of treatment), ranged from 3 (33%) to 4 (66%),
indicating either no change or minimal improvement. Additionally, only one (33%) participant
included in the final outcome analysis achieved a CGI-E score of ≥ 1.5. Table 3 shows post
intervention CGI-I and CGI-E results for participants included in the final outcome analysis and
their corresponding descriptive statistics.
Discussion
The purpose of this project was to evaluate the HBPC Program’s effectiveness at increasing
access to timely and effective psychopharmacological treatment and management. Initial results
were inconclusive yet promising. At the 12-week mark, 60% of patient referred for medication
management were under the care of a psychiatric provider (goal was ≥ 75%), 13% of referred
patients had been assessed within 10 days (goal was ≥ 75%), and 33.3% of participants included
in the final outcome analysis achieved a CGI-I score of ≤ 3 and an Efficacy Index score of ≥ 1.5
after receiving 8 weeks of treatment (goal was ≥ 40 % and ≥ 75% respectively), ultimately
falling short of the agency’s benchmarks for the program.
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Demographic Characteristics of Study Participants
Characteristic

Gender
Male
Female

No. (%) of
Referred Patients
(n = 15)

No. (%) of
Final Analysis Patients
(n = 3)

6 (40%)
9 (60%)

1 (33%)
2 (67%)

6 (40%)
3 (20%)
5 (33%)
1 (7%)

2 (67%)
1 (33%)
0 (0%)
0 (0%)

8 (53%)
1 (67%)
1 (67%)
5 (33%)

3 (100%)
0 (0%)
0 (0%)
0 (0%)

Age
60-69
70-79
80-89
90+

Relationship Status
Single
Married
Divorced
Widow/Widower

Baseline Psychiatric
Disorders
1
2
3
4+

10 (67%)
2 (13%)
2 (13%)
1 (7%)

0 (0%)
0 (0%)
2 (67%)
1 (33%)

12 (80%)
3 (20%)

3 (100%)
0 (0%)

Hx of Psychiatric
Medication Use
Yes
No

Current Psychiatric
Medication Use
Yes
No

11 (73%)
4 (27%)

3 (100%)
0 (0%)
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Table 2
Initial Psychiatric Evaluation Wait Time of Study Participants
Initial Wait Time (days)

No. (%) of Patients
(n = 15)
0-10
2 (13%)
11-19
1 (7%)
20-29
4 (27%)
30+
2 (13%)
Not Seen
6 (40%)
Note: Objective was for ≥ 75% of participants to been seen ≤ 10 days.

Table 3
Post Intervention CGI Global Improvement & Efficacy Index Results
Clinical Outcome Category
CGI-I Score
≤3
4+

No. (%) of Patients
(n = 3)
1 (33.3%)
2 (66.6%)

Efficacy Index Score
< 1.5

2 (66.6%)
1 (33.3%)
Note: Objective was for ≥ 75% of participants to achieve a CGI-I score
≥ 1.5

of ≤ 3 and an Efficacy Index score of ≥ 1.5 post intervention.

While none of the agency’s goals where fully met within the first 3 months, this project
was still considered at least partially successful in the sense that it succeeded in increasing the
percentage of patients referred for medication management who were being cared for by a
psychiatric medication provider (i.e., the agency’s PMHNP) by 24.4% in comparison to baseline
findings (i.e. from 35.6% to 60%). The project also had the secondary benefit of improving the
agency’s appreciation of the importance of ongoing program evaluation and quality
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improvement. The overall findings of this project, including the initial administrative, and
financial barriers faced during the implementation stage, were also similar to those described in
other home-based psychiatric care model studies that despite initial challenges were eventually
successful. Furthermore, this new HBPC program was found to have several key characteristics
in common with other successful programs including; (a) a strongly held belief in the need for
the program in their community, (b) an ability to work within the framework of their parent
organization, (c) the ability to form partnerships within the community, and (d) a commitment to
overcome the obstacles that constantly arise. Therefore, if improved outcomes are realized over
time, the HBPC program is anticipated to improve this agency's ability to provide
psychopharmacological care to its vulnerable homebound geriatric clientele.
Despite these successes, however, there were some challenges encountered during the
implementation stage that directly impacted the HBPC program’s overall effectiveness. For
instance, unanticipated credentialing delays at the start of the program ultimately led to initial
evaluation delays, making the agency’s goal of seeing all referred patient’s within 10 days
practically impossible to meet until corrected. There were also several design and process
weaknesses identified during this evaluation. For instance, the lack of observable clinical
improvements by the 12-week mark might indicate that the allotted timeframe for this project
was too short for detectable clinical improvements to occur. There was also the possibility that
patients were not taking their medications, as this project did not track whether the paper-based
prescriptions were filled. The lack of leadership oversight and frequent communication
breakdowns with the agency’s newly hired APRN, also led to several referred patients falling
through the cracks due to lack of follow-up.
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Limitations
This change in practice project contained numerous design limitations, including a small
convenience sample size, lack of randomization, the use of paper-based prescriptions, and
potential bias due to the use of only one psychiatric provider (i.e. agency’s APRN) providing the
treatment and outcome evaluations. Another major limitation was the short timeframe allotted
for this project, as it was insufficient to produce an effective and diverse sample size and
possibly too short to allow for detectable clinical improvements to occur. Another design
limitation that led to potential bias was that neither patients and/or caregivers perspectives were
taken into account when assessing clinical outcomes in this project; instead only the providerrated CGI-I and CGI-E scores were considered. This project also did not account for patients’
ability to afford and obtain any medications prescribed. Other limitations include the lack of
outcomes aimed at assessing the short-term financial feasibility and long-term sustainability of
this program.
Recommendations
There were seven recommendations based on the results of this program evaluation:
1. Set up regular weekly teleconferences between all team members to ensure prevent
communication breakdowns, aid troubleshooting for any barriers encountered, and to
increase accountability.
2. Consider changing Electronic Medical Record for one that allows for psychiatric
providers to order labs and prescribe medication.
3. Consider investing in hiring a billing and coding specialist to ensure proper
reimbursement for services received.
4. Consider hiring another PMHNP so that this program is not reliant on only one provider.

PROGRAM EVALUATION OF APRN-LED HBPC PROGRAM

26

5. Consider conducting another program evaluation at the 6-month mark to further evaluate

the program’s effectiveness at improving patient outcomes.
6. Consider adding financial outcomes to assess the programs feasibility and sustainability.
7. Consider the addition of other clinical outcome assessment tools that take into

consideration the patient and caregivers perspectives.
Implications for Practice
Mental illness remains grossly undertreated in the elderly, especially in those that are
homebound. As the number of older adults with mental illness is expected to reach over 15
million by 2030, there is a clear need for new innovative, evidence-based psychiatric care
delivery models designed to reach out to this vulnerable population. Home-based psychiatric
care models are designed to increase access to timely and effective psychiatric care, by allowing
frail, elderly patients to receive quality patient-centered non-pharmacological and
pharmacological interventions in their home. By bringing the services to them, this model of care
has been shown to enhance access and utilization of psychiatric services and improve psychiatric
outcomes in the elderly. This model of care has also been proven useful in helping healthcare
organizations to address the growing access to psychiatric care gaps.
As people continue to live longer, the need for home-based treatment options is only
expected to rise, making it essential that all psychiatric providers, including physicians, nurse
practitioners, social workers, and psychologist learn about home-based psychiatric care delivery
models and how they can be utilized to meet the unique needs of this vulnerable population. The
results of this project reinforce the positive impact that home-based psychiatric care models can
make in the management of older adults with mental illness unable or unwilling to access care
through community mental health clinics, serving as an essential bridge that connects the elderly

PROGRAM EVALUATION OF APRN-LED HBPC PROGRAM

27

with timely and effective psychopharmacologic interventions. This project also demonstrated
how doctorly prepared APRNs have the necessary knowledge and leadership abilities to greatly
impact patient care delivery systems and improve patient outcomes. For example, as experts in
translating evidence into practice, doctorly prepared APRNs are exceedingly equipped to assess
healthcare organizations and design, implement, and evaluate changes in practice, like the novel
care delivery model utilized in this project. Lastly, as leaders in healthcare, doctorly prepared
APRNs are uniquely prepared to urge policymakers to support the implementation of more
efficient and innovative care delivery approaches aimed at meeting the psychiatric care needs of
the underserved, vulnerable elderly population.
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